Sakata S, Miura K
Clin Ther. 1984;6(5):600-2.
Nicardipine, a new calcium antagonist, was given to an insulin-treated diabetic patient with severe hypertension that had resisted ordinary antihypertensive treatment. After substitution of treatment with nicardipine, his blood pressure decreased from 210/110 to 142/76 mmHg. Despite this significant decrease in blood pressure, the patient's renal blood flow, as estimated by endogenous creatinine clearance, increased. His daily requirement of insulin and his degree of proteinuria remained unchanged by the use of nicardipine.
尼卡地平,一种新型钙拮抗剂,被给予一位接受胰岛素治疗但严重高血压对常规抗高血压治疗无效的糖尿病患者。在用尼卡地平替代治疗后,他的血压从210/110降至142/76 mmHg。尽管血压显著下降,但通过内生肌酐清除率估计,患者的肾血流量增加。使用尼卡地平后,他的胰岛素每日需求量和蛋白尿程度保持不变。